Pfizer Stock: Innovation that matters

Pfizer Stock: Innovation that matters

Pfizer stock may not be as hyped as the COVID-19 business looks to wind down. However, with a renewed growth strategy, PFE stock can offer investors growth at a value price.

Shares of COVID vaccine maker Pfizer (PFE) are steadily trending higher again.The $300 billion biopharmaceutical company doesn’t get nearly as much press as it did a few years ago. Undoubtedly, Pfizer was met with much praise following the miraculous marvel that’s since been taken for granted.

Even as the COVID-19 business winds down, Pfizer remains one of this market’s most innovative companies and the 12.3 times trailing earnings multiple does not do its justice.

With a new growth mindset and investment in other intriguing businesses, Pfizer stock seems eager to prove it’s worthy of a much higher multiple. With a stellar management team and discounted growth capabilities, stock attempts to revisit its highs near $60 per share.



Empieza a hacer trading
en cuestión de minutos.

Abre una cuenta ahora

bullet Accede a más de 10.000 instrumentos financieros
bullet Apertura y cierre automático de posiciones
bullet Noticias y agenda económica
bullet Indicadores técnicos y gráficos
bullet Muchas más herramientas incluidas

Al proporcionar su correo electrónico, usted acepta la política de privacidad de FP Markets y está de acuerdo en recibir futuros mensajes de marketing por parte de FP Markets. Puede darse de baja en cualquier momento.





Get instant Updates in Telegram
Mapa del sitio | © FP Markets 2022